ISB News

ISB’s Dr. Eliza Peterson Earns TB Junior Investigator Award

Dr. Eliza Peterson, a senior research scientist who studies tuberculosis (TB) in the Institute for Systems Biology’s Baliga Lab, has been recognized by the University of Washington’s Tuberculosis Research and Training Center with a TB Junior Investigator Award.

“I feel like it’s not just an award for me, but for ISB and the Baliga Lab,” Peterson said in a video interview. “We’re relatively new to the TB research field, and I feel like this award is recognizing some of our research efforts and using our systems approaches to study TB.”

Peterson’s research focuses on regulatory network models to identify and understand the underlying complexity of Mycobacterium tuberculosis (MTB), the pathogen that causes TB. Peterson and collaborators have identified a regulator of essential genes necessary for the biosynthesis of mycolic acids, which make up a major component of MTB’s cell wall. These findings could potentially offer targets for future TB therapies.

The TB Junior Investigator Award recognizes the efforts of early-career scientists who have made significant contributions to the entire spectrum of TB research.

Learn more about Peterson’s research and where it will lead in the video above.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.